Logo image of NBY

NOVABAY PHARMACEUTICALS INC (NBY) Stock Analyst Ratings

NYSEARCA:NBY - US66987P4090 - Common Stock

0.9101 USD
-0.16 (-14.94%)
Last: 8/22/2025, 8:26:42 PM
0.911 USD
+0 (+0.1%)
After Hours: 8/22/2025, 8:26:42 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to NBY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 0.87. This target is -4.74% below the current price.
NBY was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NBY.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed NBY. So this is just the average opinion of a couple of analysts.

Related screens

NBY Historical Analyst RatingsNBY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -104 -94 -84 -74 -64 -54 -44 -34 -24 -14 -4 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.910.860.870.870.89 - -5.67% -4.74% -4.74% -1.93%

Related screens

NBY Current Analyst RatingNBY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-11-11 Ascendiant Capital Maintains Buy -> Buy
2023-08-11 Ladenburg Thalmann Maintains Buy -> Buy
2022-05-20 Ascendiant Capital Maintains Buy